Literature DB >> 21051034

Localized nasopharyngeal amyloidosis.

Yen-Sheng Chen1, Wing-Yin Li, Ching-Yin Ho.   

Abstract

A mass in the nasopharynx often implies a malignancy in adults, particularly in the endemic areas of Epstein-Barr virus-associated undifferentiated carcinoma. We report an 86-year-old male patient who presented to our rhinologic outpatient department with postnasal drip for several years, with no other associated nasal symptoms. Physical examination with nasal endoscopy found a prominent bulge in the nasopharynx. Pathological examination of the biopsied specimens identified features consistent with amyloidosis. Magnetic resonance imaging demonstrated an enhanced soft-tissue mass localized to the nasopharyngeal region. We excluded the possibility of a partial representation of a potential systemic amyloidosis. Regular follow-up including nasal endoscopy was undertaken. Over 3 years of observation, the disease process remained silent. Here, the clinical presentation, diagnosis and treatment options of this rare entity are discussed.
Copyright © 2010 Elsevier. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21051034     DOI: 10.1016/S1726-4901(10)70119-2

Source DB:  PubMed          Journal:  J Chin Med Assoc        ISSN: 1726-4901            Impact factor:   2.743


  3 in total

1.  Localized Nasopharyngeal Amyloidosis: A Clinicopathologic Series of 7 Cases with a Literature Review.

Authors:  Georgios Sakagiannis; Evangelos Giotakis; Lester D R Thompson
Journal:  Head Neck Pathol       Date:  2017-12-27

Review 2.  Amyloidosis of the Upper Aerodigestive Tract: Management of a Rare Disease and Review of the Literature.

Authors:  Thorsten Send; Jennifer L Spiegel; Goetz Schade; Annette Pantelis; Arno Olthoff; Friedrich Bootz; Martin Canis; Mark Jakob
Journal:  Dysphagia       Date:  2018-10-31       Impact factor: 3.438

3.  Localized nasopharyngeal amyloidosis mimicking malignancy: A case report.

Authors:  Jong Seung Kim; Sam Hyun Kwon
Journal:  Medicine (Baltimore)       Date:  2017-07       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.